Used primarily as an anticonvulsant in the management of absence seizures (petit mal epilepsy), particularly in pediatric patients. It helps reduce the frequency of brief loss of consciousness and staring spells associated with this type of seizure. While not a first-line treatment, it may be considered when other medications are ineffective or poorly tolerated. Its use has declined over time due to the availability of newer agents with better safety profiles.